Heated Drug Pricing Debate Fanned By Election, Teva's Olafsson Says

'I can't wait until it's over,' Teva's Generic Medicines CEO Sigurdur Olafsson said of the US Presidential election; then the current debate around drug pricing will return to a discussion of value, he predicted.